Engineers Gate Manager’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.7K Buy
39,494
+7,840
+25% +$16.1K ﹤0.01% 2068
2025
Q4
$62.7K Buy
31,654
+17,335
+121% +$55.5K ﹤0.01% 1959
2025
Q3
$41.7K Buy
+14,319
New +$32.9K ﹤0.01% 2070
2025
Q1
Sell
-48,058
Closed -$113K 2523
2024
Q4
$113K Buy
+48,058
New +$844K ﹤0.01% 1981
2024
Q1
Sell
-37,249
Closed -$838K 2255
2023
Q4
$838K Buy
+37,249
New +$787K 0.02% 897
2023
Q2
Sell
-13,689
Closed -$330K 1994
2023
Q1
$330K Buy
+13,689
New +$379K 0.01% 1194
2022
Q1
Sell
-7,532
Closed -$329K 2258
2021
Q4
$329K Buy
+7,532
New +$395K 0.01% 1336
2021
Q2
Sell
-15,420
Closed -$693K 1969
2021
Q1
$693K Buy
+15,420
New +$606K 0.03% 797

Other funds holding FLNA

Engineers Gate Manager's FLNA Position: Q1 2026 in Review

Engineers Gate Manager increased its Filana Therapeutics (FLNA) stake by 25% in Q1 2026, buying an estimated $16.1K and bringing the position to 39,494 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Engineers Gate Manager first reported a position in FLNA in Q1 2021 and has held it in 8 quarters since. The position peaked at $838K in Q4 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Engineers Gate Manager held 39,494 shares of Filana Therapeutics worth $66.7K as of Q1 2026.
  • Engineers Gate Manager bought 7,840 Filana Therapeutics shares in Q1 2026, an estimated $16.1K.
  • Filana Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2068 holding.
  • Engineers Gate Manager first reported a position in Filana Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • Engineers Gate Manager's Filana Therapeutics position peaked at $838K in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.